MarshallS.D., SandersonP., McIntoshC.A., KolawoleH.The effect of two cognitive aid designs on team functioning during intra-operative anaphylaxis emergencies: a multi-centre simulation study. Anaesthesia2016; 71: 389–404.
FlorvaagE., JohanssonS.G.O.The pholcodine case. Cough medicines, IgE sensitisation, and anaphylaxis: a devious connection. World Allergy Organ J2012; 5: 73–78.
7.
FlorvaagE., JohanssonS.G., IrgensA., de PaterG.H.IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy2011; 66: 955–960.
8.
de PaterG.H., FlorvaagE., JohanssonS.G.O., IrgensA., PetersenM.H.N., GuttormsenA.B.Six years without pholcodine; Norwegians are significantly less IgE sensitized and clinically more tolerant to neuromuscular blocking agents. Allergy2017 (in print doi: 10.1111/all.13081).
EquinozziR., RobuschiM.Comparative efficacy and tolerability of pholcodine and dextromethorphan in the management of patients with acute, non-productive cough: a randomized, double-blind, multicenter study. Treat Respir Med2006; 5: 509–513.
11.
SmithS.M., SchroederK., FaheyT.Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev2012; CD001831.
12.
KatelarisC.H., KurosawaM., MoonH-B, BorresM., FlorvaagE., JohanssonS.G.O.Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan. Asia Pac Allergy2014; 4: 86–90.